Cargando…

2.3 Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular course juvenile rheumatoid arthritis (JRA): Findings from an open-label treatment extension

Detalles Bibliográficos
Autores principales:	Ruperto, N, Lovell, DJ, Cuttica, R, Woo, P, Espada, G, Wouters, C, Silverman, ED, Balogh, Z, Henrickson, M, Davidson, J, Foeldvari, I, Imundo, L, Simonini, G, Oppermann, J, Shen, YK, Visvanathan, S, Fasanmade, A, Mendelsohn, A, Martini, A, Giannini, EH
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334187/ http://dx.doi.org/10.1186/1546-0096-6-S1-S3

Ejemplares similares

Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension
por: Ruperto, Nicolino, et al.
Publicado: (2009)

The effect of infliximab plus methotrexate on the modulation of inflammatory disease markers in juvenile idiopathic arthritis: analyses from a randomized, placebo-controlled trial
por: Visvanathan, Sudha, et al.
Publicado: (2010)

Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis
por: Ruperto, Nicolino, et al.
Publicado: (2021)

Efficacy and Safety of Tocilizumab for Polyarticular‐Course Juvenile Idiopathic Arthritis in the Open‐Label Two‐Year Extension of a Phase III Trial
por: Brunner, Hermine I., et al.
Publicado: (2021)

Open-label phase 3 study of intravenous golimumab in patients with polyarticular juvenile idiopathic arthritis
por: Ruperto, Nicolino, et al.
Publicado: (2021)

The clinical significance of anti-CCP antibodies in Korean JRA patients
por: Kim, Kwang Nam, et al.
Publicado: (2014)

7.5 Safety data from over 1,200 patients-years of methotrexate and/or etanercept treatment in children with polyarticular or systemic juvenile rheumatoid arthritis
por: Giannini, EH, et al.
Publicado: (2008)

Subcutaneous Abatacept in Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis: Results From a Phase III Open‐Label Study
por: Brunner, Hermine I., et al.
Publicado: (2018)

PW01-014 – MEFV methylation analysis in FMF and JRA diseases
por: Turanli, E Tahir, et al.
Publicado: (2013)

Maintenance of antibody response to diphtheria/tetanus vaccine in patients aged 2–5 years with polyarticular-course juvenile idiopathic arthritis receiving subcutaneous abatacept
por: Brunner, Hermine I., et al.
Publicado: (2020)

PReS-FINAL-2180: Efficacy and safety of tocilizumab (TCZ) in patients with polyarticular-course juvenile idiopathic arthritis (pcJIA): 2-year data from CHERISH
por: De Benedetti, F, et al.
Publicado: (2013)

Suspected anemia caused by maternal anti-Jra antibodies: a case report
por: Endo, Yasufumi, et al.
Publicado: (2015)

Safety and Effectiveness of Adalimumab in Patients With Polyarticular Course of Juvenile Idiopathic Arthritis: STRIVE Registry Seven‐Year Interim Results
por: Brunner, Hermine I., et al.
Publicado: (2020)

Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: results of a phase 1, open-label, multicenter study
por: Ruperto, Nicolino, et al.
Publicado: (2017)

Long-term outcomes in patients with polyarticular juvenile idiopathic arthritis receiving adalimumab with or without methotrexate
por: Lovell, Daniel J, et al.
Publicado: (2020)

Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial
por: Brunner, Hermine I, et al.
Publicado: (2015)

CARE-JRA2* Activities on Photo-Injectors and CLIC Test Facility (CTF3)
por: Rinolfi, Louis
Publicado: (2005)

CARE/JRA4: Status Report of the 4th Quarter of 2004: Next European Dipole (NED)
por: Devred, Arnaud, et al.
Publicado: (2005)

CARE/JRA4: Status Report of the 4th Quarter of 2005: Next European Dipole (NED)
por: Devred, Arnaud, et al.
Publicado: (2006)

7.4 Improvements in individual disease components are sustained with long-term adalimumab therapy for polyarticular Juvenile Idiopathic Arthritis
por: Ruperto, N, et al.
Publicado: (2008)

Abatacept treatment improves health-related quality of life, pain, and sleep quality in juvenile idiopathic arthritis patients
por: Ruperto, N, et al.
Publicado: (2008)

Treating to target of minimal disease activity and normal function in polyarticular juvenile idiopathic arthritis with adalimumab: analysis from a phase 3 clinical trial
por: Ruperto, Nicola, et al.
Publicado: (2014)

Report 1 PHIN-CARE-JRA2-WP3 Second Task: Pulse Shaping
por: Boscolo, I, et al.
Publicado: (2005)

Pneumococcal polyarticular septic arthritis after a single infusion of infliximab in a rheumatoid arthritis patient: a case report
por: Hayashi, Masatoshi, et al.
Publicado: (2012)

Value of ultrasound in detecting subclinical synovitis in polyarticular juvenile idiophatic arthritis (PJIA) in clinical remission (CR)
por: Meiorin, Silvia, et al.
Publicado: (2014)

Open label multicenter study of once weekly Etanercept 0.8 mg/kg in active polyarticular Juvenile idiopathic arthritis (JIA)
por: Horneff, G, et al.
Publicado: (2008)

Summary and Conclusions of the 'JRA Beam Telescope 2025'-Forum at the 6th Beam Telescopes and Test Beams Workshop
por: Dreyling-Eschweiler, J., et al.
Publicado: (2018)

Polyarticular septic arthritis in an immunocompetent patient
por: Clements, J, et al.
Publicado: (2013)

Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial
por: Brunner, Hermine I, et al.
Publicado: (2018)

Possible alendronate-induced polyarticular synovitis
por: Gökkuş, K, et al.
Publicado: (2016)

Protocols on classification, monitoring and therapy in children’s rheumatology (PRO-KIND): results of the working group Polyarticular juvenile idiopathic arthritis
por: Horneff, Gerd, et al.
Publicado: (2017)

PReS-FINAL-2070: Efficacy of biologic treatments in juvenile idiopathic arthritis with a polyarticular course: an indirect comparison
por: Sawyer, L, et al.
Publicado: (2013)

Population pharmacokinetic analysis of infliximab in patients with ulcerative colitis
por: Fasanmade, Adedigbo A., et al.
Publicado: (2009)

Successful Management of the Fetal Severe Anemia Associated with Jra Alloimmunization by Intrauterine Transfusion of Jr(a+) Red Blood Cells
por: Toshimitsu, Masatake, et al.
Publicado: (2019)

A Case of Polyarticular Pasteurella multocida Septic Arthritis
por: Nitoslawski, Sarah, et al.
Publicado: (2016)

Advances in the treatment of polyarticular juvenile idiopathic arthritis
por: Webb, Kate, et al.
Publicado: (2015)

Polyarticular tuberculosis: A rheumatoid arthritis mimic
por: Kumar, Dunga Sai, et al.
Publicado: (2020)

The value of the patient global health assessment in polyarticular juvenile idiopathic arthritis: a nested cohort study
por: Trachtman, Rebecca, et al.
Publicado: (2021)

Radiological cervical spine involvement in polyarticular idiopathic juvenile arthritis
por: Wipff, J, et al.
Publicado: (2011)

Oral or Parenteral Methotrexate for the Treatment of Polyarticular Juvenile Idiopathic Arthritis
por: Bakry, Reima, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_crb1b3ssj22voc0lm87jhss0vp